Department of Medicine O, Centre of Endocrinology and Metabolism, Herlev University Hospital, DK-2730, Denmark.
Scand J Clin Lab Invest. 2013 Apr;73(3):240-4. doi: 10.3109/00365513.2013.769623. Epub 2013 Feb 26.
Painless thyroiditis (PT) is a transient kind of thyrotoxicosis, with lack of uptake on a thyroid scintigraphy in a non-tender thyroid gland, elevated anti-TPO antibodies, no fever, no history of increased iodine intake, and a normal sedimentation rate. The prevalence of PT varies hugely in the literature.
To establish the incidence rate of PT in Denmark as well as to describe the phenotype of PT in more detail.
Tc-99m pertechnetate scintigraphies were performed over a period of 9.75 years on 6022 consecutive patients (2349 had a thyrotoxic episode), and were divided into high or normal (5528), reduced (300) or lack of uptake (194). Patient records were evaluated: 292 with reduced, and 186 with lack of uptake. As a control measure, 230 consecutive thyrotoxic patients were also analyzed.
Based on scintigraphies, 12 patients had PT, 10 with lack of uptake and two with reduced, corresponding to an incidence rate of 0.49/100,000 person years. It was predicted, that only one patient among the newly diagnosed consecutive thyrotoxic cohort had PT. This patient was identified. The prevalence of PT among thyrotoxic patients was 0.51% as evaluated by scintigraphy, and 0.43% among the biochemically thyrotoxic patient cohort. Twenty-five percent had more than one thyrotoxic episode, 75% had at least one subsequent hypothyroid episode, and 33% developed permanent hypothyroidism.
PT presenting with symptomatic thyrotoxicosis is an extremely rare disease in Denmark. Symptomatic PT presents most often with no uptake on a Tc-99m pertechnetate scintigraphy. Clinical follow-up is essential.
无痛性甲状腺炎(PT)是一种短暂的甲状腺毒症,表现为触诊无触痛的甲状腺摄取放射性碘减少、抗甲状腺过氧化物酶抗体升高、无发热、无碘摄入增加史、血沉正常。PT 的患病率在文献中差异很大。
确定丹麦 PT 的发病率,并更详细地描述 PT 的表型。
对 6022 例连续患者(2349 例出现甲状腺毒症发作)进行了 9.75 年的 Tc-99m 过锝酸盐闪烁显像,并将其分为高摄取或正常摄取(5528 例)、减少摄取(300 例)或无摄取(194 例)。评估患者记录:292 例为减少摄取,186 例为无摄取。作为对照措施,还对 230 例连续甲状腺毒症患者进行了分析。
根据闪烁显像,12 例患者患有 PT,10 例为无摄取,2 例为摄取减少,发病率为 0.49/100000 人年。预计新诊断的连续甲状腺毒症队列中只有 1 例患者患有 PT。这名患者被识别出来。通过闪烁显像评估,PT 在甲状腺毒症患者中的患病率为 0.51%,在生化甲状腺毒症患者队列中为 0.43%。25%的患者有超过一次甲状腺毒症发作,75%的患者至少有一次后续甲状腺功能减退发作,33%的患者发展为永久性甲状腺功能减退。
在丹麦,以症状性甲状腺毒症为表现的 PT 是一种极为罕见的疾病。症状性 PT 最常见的表现为 Tc-99m 过锝酸盐闪烁显像无摄取。临床随访至关重要。